Skip to main content
Log in

Current Insurance Policy Coverage for Screening Mammography in Transgender and Gender-Diverse Individuals

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

References

  1. Clarke CN, Cortina CS, Fayanju OM, Dossett LA, Johnston FM, Wong SL. Breast cancer risk and screening in transgender persons: a call for inclusive care. Ann Surg Oncol. 2022;29(4):2176–80. https://doi.org/10.1245/s10434-021-10217-5.

    Article  PubMed  Google Scholar 

  2. Caughey AB, Krist AH, Wolff TA, et al. USPSTF approach to addressing sex and gender when making recommendations for clinical preventive services. JAMA. 2021;326(19):1953–61. https://doi.org/10.1001/jama.2021.15731.

    Article  PubMed  Google Scholar 

  3. Cortina CS. Assessing breast and ovarian cancer risk prior to gender-affirming surgery. JAMA Surg. 2023;158(4):339–40. https://doi.org/10.1001/jamasurg.2022.5447.

    Article  PubMed  Google Scholar 

  4. Eckhert E, Lansinger O, Ritter V, et al. Breast cancer diagnosis, treatment, and outcomes of patients from sex and gender minority groups. JAMA Oncol. 2023;9:473. https://doi.org/10.1001/jamaoncol.2022.7146.

    Article  PubMed  Google Scholar 

  5. Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS. Perceptions of transgender and nonbinary persons toward breast and cervical cancer development, screening, and potential impact on gender-affirming hormone therapy. JCO Oncol Pract. 2023;19:e794–800. https://doi.org/10.1200/OP.22.00681.

    Article  PubMed  Google Scholar 

  6. de Blok CJM, Wiepjes CM, Nota NM, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ. 2019;365:1652. https://doi.org/10.1136/bmj.l1652.

    Article  Google Scholar 

Download references

Funding

CSC is supported by the National Institutes of Health (NIH) under Award Number 1K08CA276706-01A1 (PI: Cortina). JMN is suppored by the NIH under Award Number 5U18HS028738-02 (PI:Brown). AEP is supported by the NIH under Award Number 1R01NR020770-01 (PI: Walsh). MS is supported by the NIH under Award Number 5R01CA258759-02 (PI: Stolley) and 1T32CA269115-01A1 (PI: Stolley). The content of this manuscript is soley the responsiblity of the authors and does not neccessarily represent the official views of the NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chandler S. Cortina MD, MS, FSSO, FACS.

Ethics declarations

DISCLOSURES

The authors have no relevant disclosures to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cortina, C.S., Siegel, E.L., Polovneff, A. et al. Current Insurance Policy Coverage for Screening Mammography in Transgender and Gender-Diverse Individuals. Ann Surg Oncol 30, 6978–6980 (2023). https://doi.org/10.1245/s10434-023-14195-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14195-8

Navigation